We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAAS:TSXPan American Silver Corp. Analysis

Data as of 2026-09-13 - not real-time

CA$69.74

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Pan American Silver Corp. is neutral at CAD 69.74, with no clear ordering between short and long averages. Over a rolling month the price has gained 16.6%. Momentum indicators put RSI at 49.2 (neutral) with MACD reading bearish. Watch CAD 64.40 as support and CAD 77.36 as the nearer resistance level.
Multiples put this in undervalued territory at a P/E of 14.9. Sell-side targets cluster 32.7% above the current quote. Revenue is growing at 38.4% on a 32.0% profit margin. The 1.46% dividend yield looks covered by current payout levels.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 58.3%, a beta of 1.83 and a maximum drawdown of 37.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.

Top Market Events

VANCOUVER, British Columbia, July 09, 2026--Pan American Silver Corp.Seeking Alpha1monPan American Silver Corp.ad-hoc-news1monPAAS stock trades on Pan American Silver guidance and silver outputPAAS stock is shaped by Pan American...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 72.83
  • MACD momentum is negative
  • 30-day price change of +16.6%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 72.83
  • Analyst targets imply +32.7% versus the current price
  • 30-day volatility of 58.3%

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +32.7% versus the current price
  • Profit margin of 32.0% is healthy
  • Revenue growth of +38.4%

Key Metrics & Analysis

Financial Health

Revenue Growth38.40%
Profit Margin32.03%
P/E Ratio14.9
ROE22.41%
ROA11.77%
Debt/Equity11.43
P/B Ratio2.8
Op. Cash FlowCA$1.7B
Free Cash FlowCA$1.3B

Technical Analysis

TrendNeutral
RSI49.2
SupportCA$64.40
ResistanceCA$77.36
MA 20CA$71.15
MA 50CA$66.74
MA 200CA$72.83
MACDBearish
VolumeStable
Fear & Greed Index93.14

Valuation

Fair ValueCA$108.89
Target PriceCA$92.52
Upside/Downside32.66%
GradeUndervalued
TypeBlend
Dividend Yield1.46%

Risk Assessment

Beta1.83
Volatility58.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.